Skip to product information
1 of 1

Shulph Ink

Adverse Drug Reactions: Third Edition

Adverse Drug Reactions: Third Edition

Low Stock: Only 2 copies remaining
Regular price £50.60 GBP
Regular price £55.00 GBP Sale price £50.60 GBP
8% OFF Sold out
Tax included. Shipping calculated at checkout.

YOU SAVE £4.40

  • Condition: Brand new
  • UK Delivery times: Usually arrives within 2 - 3 working days
  • UK Shipping: Fee starts at £2.39. Subject to product weight & dimension
Trustpilot 4.5 stars rating  Excellent
We're rated excellent on Trustpilot.
  • More about Adverse Drug Reactions: Third Edition

Adverse drug reactions are a significant burden on healthcare, causing morbidity and mortality. Healthcare professionals must understand the problem and be aware of how to prevent and manage them.

Format: Paperback / softback
Length: 496 pages
Publication date: 30 March 2023
Publisher: Pharmaceutical Press


Medicines continue to pose a significant challenge to healthcare, resulting in substantial morbidity and mortality. In addition to being familiar with the benefits of medications, healthcare professionals must have a comprehensive understanding of the issue of adverse drug reactions and be equipped with the knowledge necessary to prevent and manage these reactions effectively.

Adverse drug reactions (ADRs) are a significant public health concern that affects individuals of all ages and backgrounds. These reactions can range from mild to severe, and can even be life-threatening. ADRs can occur at any stage of the drug development and distribution process, from pre-clinical testing to post-marketing surveillance.

One of the primary causes of ADRs is the lack of proper drug labeling and prescribing. Many medications are prescribed without proper consideration of the individual patient's medical history, current medications, and potential drug interactions. This can lead to incorrect dosing, incorrect timing of administration, or the use of multiple medications that can interact negatively.

Another cause of ADRs is the genetic predisposition of individuals to certain medications. Some individuals may have genetic variations that make them more susceptible to certain side effects or reactions to medications. This can make it difficult for healthcare professionals to determine the appropriate medication and dosage for an individual patient.

In addition to these causes, ADRs can also be caused by environmental factors, such as exposure to toxins or contaminated food and water. Certain medications, such as chemotherapy drugs, can also be associated with severe side effects that can be life-threatening.

The consequences of ADRs can be severe and can include hospitalization, disability, and even death. In addition to the physical and emotional toll on individuals and their families, ADRs can also result in significant economic costs to healthcare systems.

To prevent and manage ADRs, healthcare professionals must work collaboratively with patients, their families, and other healthcare providers. This includes educating patients about the potential side effects of medications, providing clear instructions on how to take medications, and monitoring patients for any potential side effects.

Healthcare professionals must also be aware of the risk factors that can increase the likelihood of ADRs, such as age, gender, medical history, and concurrent medications. This information can help healthcare professionals identify patients who are at higher risk of experiencing ADRs and take appropriate precautions.

In addition to prevention and management strategies, healthcare professionals must also be aware of the legal and ethical implications of ADRs. This includes ensuring that patients are fully informed about the risks and benefits of medications, and that healthcare professionals are held accountable for any harm that may be caused by their negligence or incompetence.

In conclusion, ADRs continue to pose a significant burden on healthcare, resulting in substantial morbidity and mortality. To prevent and manage ADRs, healthcare professionals must have a comprehensive understanding of the issue, be aware of the risk factors that can increase the likelihood of ADRs, and work collaboratively with patients, their families, and other healthcare providers. By taking these steps, healthcare professionals can help ensure that patients receive the appropriate medications and that ADRs are minimized as much as possible.

Weight: 739g
Dimension: 234 x 156 x 26 (mm)
ISBN-13: 9780857114006
Edition number: 3rd Revised edition

UK and International shipping information

UK Delivery and returns information:

  • Delivery within 2 - 3 days when ordering in the UK.
  • Shipping fee for UK customers from £2.39. Fully tracked shipping service available.
  • Returns policy: Return within 30 days of receipt for full refund.

International deliveries:

Shulph Ink now ships to Australia, Belgium, Canada, France, Germany, Ireland, Italy, India, Luxembourg Saudi Arabia, Singapore, Spain, Netherlands, New Zealand, United Arab Emirates, United States of America.

  • Delivery times: within 5 - 10 days for international orders.
  • Shipping fee: charges vary for overseas orders. Only tracked services are available for most international orders. Some countries have untracked shipping options.
  • Customs charges: If ordering to addresses outside the United Kingdom, you may or may not incur additional customs and duties fees during local delivery.
View full details